MedPath

Oxygen Saturation Monitoring in Bronchiolitis

Not Applicable
Completed
Conditions
Bronchiolitis
Interventions
Other: Continuous oxygen monitoring
Other: Intermittent oxygen monitoring
Registration Number
NCT02947204
Lead Sponsor
The Hospital for Sick Children
Brief Summary

The investigators will conduct a study around the best way to monitor infants hospitalized with bronchiolitis, the most common lung infection and a leading reason for hospitalization in infants. Infants with bronchiolitis have breathing difficulties and are provided supplemental oxygen if their oxygen levels are low. However, there is uncertainty regarding how to best monitor oxygen levels. A probe placed on the hand or foot can be used to monitor oxygen levels all the time (continuous oxygen monitoring) or just every 4-6 hours (intermittent oxygen monitoring). Research has suggested that placing infants with bronchiolitis on continuous monitoring results in unnecessary use of oxygen and infants staying longer in hospital. However, due to the lack of high quality research, its unclear which strategy is best and practice varies. The objective of this study is to conduct high quality research across hospitals to determine whether intermittent compared to continuous oxygen monitoring will reduce the length of hospital stay in infants hospitalized with bronchiolitis. The investigators will also compare safety and cost. The results of this study will inform bronchiolitis practice standards and the best use of health care resources.

Detailed Description

BACKGROUND This research protocol focuses on bronchiolitis, a leading cause of infant hospitalization and cumulative expense for the health care system. Supportive management, such as oxygen supplementation and monitoring, is the major focus of care, as active medical treatment is not effective. Oxygen saturation monitoring may be performed on an intermittent (e.g. every 4-6hrs) or continuous basis for stable infants hospitalized with bronchiolitis. Observational studies find that the use of continuous monitoring is associated with overuse of supplemental oxygen and longer hospital stay. Based on this low quality evidence, practice guidelines state that clinicians may choose not to use continuous monitoring and practice variation exists due to a lack of RCTs.

SPECIFIC AIMS Primary: To determine if intermittent vs continuous oxygen saturation monitoring will reduce length of hospital stay in infants with bronchiolitis. Secondary: To determine differences in other outcomes - effectiveness, safety, acceptability, and cost.

METHODOLOGY Design: multi-centre, pragmatic, parallel group, 1:1, two arm superiority RCT. Population: Previously healthy infants (4 weeks-2 years) hospitalized with bronchiolitis who are clinically stable, will be recruited from children's and community hospitals in Ontario, Canada.

Interventions: Randomization to intermittent (every 4hrs) or continuous oxygen saturation monitoring. In keeping with local and national clinical practice guidelines, an acceptable oxygen saturation target of ≥ 90% will be used for both groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
219
Inclusion Criteria
  • Clinical diagnosis of bronchiolitis as determined by the attending physician.
  • First episode of acute bronchiolitis.
  • Age: 4 weeks to 24 months.
  • Clinical status stable for 6 hours
  • Parent consent
Exclusion Criteria
  • Known risk factors for clinical deterioration including chronic medical condition; premature birth (<35weeks), history of apnea, weight < 4kg, receiving morphine
  • Patient on heated high flow oxygen at enrolment
  • ICU admission on current admission
  • No telephone available

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Continuous oxygen monitoringContinuous oxygen monitoringOxygen saturation will be measured continuously through the child's hospital stay until discharge.
Intermittent oxygen monitoringIntermittent oxygen monitoringOxygen saturation will be measured intermittently, every 4 hours, through the child's hospital stay until discharge.
Primary Outcome Measures
NameTimeMethod
Length of hospital stay from randomization on the inpatient unit to discharge from hospital1 month
Secondary Outcome Measures
NameTimeMethod
Number of medical interventions performed from time of randomization to hospital discharge1 month
Nursing satisfaction1 month

The attending nurse will be asked to complete a 10 mm visual analogue scale (VAS) to measure their satisfaction with the quality of monitoring.

Number of parent work days missed from randomization to 15 days after discharge15 days after discharge
Duration of oxygen supplementation from randomization to discontinuation of supplementation1 month
Parent anxiety1 month

Parents will rate their level of anxiety at the current time (state anxiety) and generally (trait anxiety) from the adult State Trait Anxiety Inventory questionnaire during the hospital stay.

Time from randomization to meeting hospital discharge criteria1 month
Length of hospital stay from inpatient unit admission to hospital discharge1 month
Unscheduled return to care within 15 days of discharge15 days after discharge
Mortality15 days after discharge.
PICU admission after randomization1 month
PICU consultation after admission1 month
Cost-Effectiveness15 days after discharge.

Cost-effectiveness will be measured by the incremental cost-effectiveness ratio (ICER), a ratio defined by the incremental difference in costs between treatment arms and the incremental difference in length of stay.

Trial Locations

Locations (6)

Trillium Health Partners (Credit Valley Site)

🇨🇦

Mississauga, Ontario, Canada

McMaster Children's Hospital

🇨🇦

Hamilton, Ontario, Canada

Children's Hospital of Eastern Ontario

🇨🇦

Ottawa, Ontario, Canada

North York General Hospital

🇨🇦

Toronto, Ontario, Canada

Lakeridge Health Oshawa

🇨🇦

Oshawa, Ontario, Canada

Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath